{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-017739","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2024-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.074619+00:00","generated_at":"2026-06-02T23:01:26.911396+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Palisade Bio announces $4M private placement of common stock and pre-funded warrants","bullets":["Gross proceeds of $4M from sale of 615,242 shares/pre-funded warrants at $6.5015 each.","Issuing 922,863 common warrants with 7-year term at $6.314 per share.","Ladenburg Thalmann as placement agent; closing on or about May 6, 2024.","Net proceeds for working capital and general corporate purposes.","Company to file registration statement for resale within 10 days post-closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-017739","json":"https://secwatch.observer/filing/0001493152-24-017739.json","markdown":"https://secwatch.observer/filing/0001493152-24-017739.md","text":"https://secwatch.observer/filing/0001493152-24-017739.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224017739/0001493152-24-017739-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224017739/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:01:26.911396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"caf8da4e9eb4fa2e9bd495ad4eecc282dbf4e9d9","claim":"PALISADE BIO, INC. entered into Purchase Agreement with an institutional investor valued at approximately $4.0 million (effective 2024-05-01).","evidence_excerpt":"On May 1, 2024, Palisade Bio, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Purchaser”), pursuant to which the Company agreed to sell and issue, in a private placement, (i) 85,100 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”) and (ii) 530,142 prefunded warrants (the “Prefunded Warrants”) at a purchase price per Share or Prefunded Warrant of $6.5015 (less the applicable exercise price of each Prefunded Warrant purchased) (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224017739/0001493152-24-017739-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an institutional investor"},{"label":"Value","value":"approximately $4.0 million"},{"label":"Effective","value":"2024-05-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}